Active Not RecruitingNCT06087458
Study of VOY-101 in Patients With Advanced Non-Neovascular Age-Related Macular Degeneration
PHASE1 · PHASE2 · 60 planned enrolment
- Countries listed
- 3
- Registry update
- August 17, 2026
immortal.lifeTrial registrations containing the exact intervention label VOY-101.
No aliases or equivalent products have been inferred.
This is a registry availability fact, not a safety result, comparison, or conclusion.
Understand the safety boundary →PHASE1 · PHASE2 · 60 planned enrolment
Phase not reported · 88 planned enrolment
PHASE1 · PHASE2 · 45 planned enrolment